Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) (RFA-HG-23-017)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional) (RFA-HG-23-018)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) (PAR-23-179)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed (PAR-23-268)

Sponsor: National Center for Advancing Translational Sciences

Due Date: Multiple due dates; see announcement. LOI due 30 days before application.

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) (PAR-23-267)

Sponsor: National Center for Advancing Translational Sciences

Due Date: Multiple due dates; see announcement. LOI due 30 days before application.

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) (PAR-23-165)

Sponsor: National Institute of Mental Health, National Institute on Aging

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Exploratory Research Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) (RFA-DC-24-001)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) (PAR-23-164)

Sponsor: National Institute of Mental Health, National Institute on Aging

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (RFA-NS-24-004)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $10,000,000 per year to fund 15-20 awards.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) (RFA-NS-24-005)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $10,000,000 per year to fund 15-20 awards.

Due Date: Multiple dates; see announcement.

Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes (NOT-AG-23-004)

Sponsor: National Institute on Aging

Due Date: See announcement.

Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (PAR-23-112)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) (RFA-AG-24-001)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (PAR-23-082)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)" (NOT-NS-23-049)

Sponsor: National Institute of Neurological Disorders and Stroke